United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
555.91
+8.76 (1.60%)
At close: Jul 2, 2026, 4:00 PM EDT
555.74
-0.17 (-0.03%)
After-hours: Jul 2, 2026, 7:49 PM EDT
United Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 29, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $516 | Hold | Maintains | $516 | -7.18% | Jun 5, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $660 → $675 | Buy | Maintains | $660 → $675 | +21.42% | Jun 5, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $660 | Buy | Maintains | $660 | +18.72% | May 29, 2026 |
Unknown Analyst J.P. Morgan No rating | J.P. Morgan | Buy Maintains $685 | Buy | Maintains | $685 | +23.22% | May 20, 2026 |
| Jefferies | Jefferies | Buy Maintains $668 → $733 | Buy | Maintains | $668 → $733 | +31.86% | May 19, 2026 |
| Wells Fargo | Wells Fargo | Buy Upgrades $575 → $738 | Buy | Upgrades | $575 → $738 | +32.76% | May 7, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $707 → $701 | Buy | Maintains | $707 → $701 | +26.10% | May 7, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.